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Abstract
 .   . . The effect of poly ethylene glycol cholesteryl ethers PEG n -Chols with two different numbers of units ns50 and
.200 in the hydrophilic PEG moiety on cellular endocytic activity was studied on HT-1080 cells. The amphipathic
molecules were soluble in aqueous solution. When fluorescein derivatives of PEG-Chols one fluorescein at the distal end of
.PEG were incubated with the cells in culture, the cellular fluorescence was localized at the plasma membrane level and in
 .intracellular vesicles. Fluorescence quantification indicated that for the same external concentration, twice more FPEG 50 -
 .Chol than FPEG 200 -Chol was associated with the cells under the same conditions. Regardless of the length of PEG
moiety, PEG-Chols’ interaction with cells reduced the endocytic internalization of a fluid phase marker, horseradish
 . 125peroxidase HRP depending on the cell-associated amount. In contrast, internalization of I-labeled epidermal growth
 .  .factor EGF through receptor-mediated endocytosis did not change upon incubation with PEG 50 -Chol. The effect of
 .PEG 200 -Chol was also small, since EGF internalization showed a reduction of 10–20%, while at the same concentration
 .as much as 80% of HRP uptake was inhibited. PEG 50 -Chol did not influence the internalization of a larger ligand,
125  .  . 125I-transferrin Tfn . However, in the presence of PEG 200 -Chol, the uptake of I-Tfn decreased remarkably, and yet,
 .PEG 200 -Chol has no influence on the binding and internalization of a monoclonal antibody directed toward the
ectodomain of the Tfn-receptor. These results suggested that incorporation of PEG-Chols in the outer monolayer of the
plasma membrane specifically inhibited clathrin-independent, but not clathrin-dependent endocytosis. q 1997 Elsevier
Science B.V.
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1. Introduction
 . Poly ethylene glycol cholesteryl ethers PEG-
.Chols are a group of nonionic amphipathic molecules
consisting of hydrophobic cholesteryl and hydrophilic
 .  .poly ethylene glycol moieties Fig. 1 . A variety of
these amphipathic molecules with different PEG
length have been tested for pharmaceutical uses. The
molecule with ns3, spontaneously forms liposomes
w xin aqueous solutions 1 , while those with ns8 or
w x  .more make micelles 2–4 . PEG 24 -Chol has been
used as a solubilizer for the polyene antibiotic
w xamphotericin B 5 and as a enhancer on the intestinal
w xabsorption of peptides 6,7 . Recently, PEG-Chols
with larger numbers of units have been used to
introduce modifications on the liposomal surfaces.
 .Particularly, liposomes coated with PEG 200 -Chol
were studied in vivo as models for carriers of water-
w xsoluble drugs 8 . They exhibited a markedly longer
blood-circulation time and a lower accumulation to
the reticuloendothelial system.
PEG-Chols with different length of PEG moiety
have been known to give different effects on the
 .blood components. PEG 24 -Chol has been shown to
w xinduce hemolysis of red blood cells 5 . PEG-Chols
with 25 and 30 PEG units show the maximum
 .  .hemolytic activity, while PEG 8 -Chol or PEG 50 -
w xChol have none 3,4 . Similar dependence on the
length of PEG for the toxic activity has been reported
w xfor simple alkyl derivatives of PEGs 9,10 . Micellar
assemblies of these PEG-Chols with larger PEG were
thought to interact with cells in organs, particularly,
w xmacrophages resident in liver and spleen 8 .
Numerous block copolymer, such as poloxamer
F108, poloxamine T908 which consists of polypropy-
 .Fig. 1. Chemical structure of poly ethylene glycol cholesteryl
 .ether. n is the average of ethylene glycol units repeated num-
ber.
w xlene oxide and polyethylene oxide 11 and Antarox
 . w xCO p-nonylphenol-polyethylene oxide 12 have
been shown to inhibit internalization of polystyrene
particles in primary cultures of phagocytes. These
authors suggested that absorption of these amphi-
pathic molecules on the cell surfaces prevented the
binding of the polystyrene particles and then the
phagocytic process. We previously found that the
presence of PEG-Chols with various chain lengths in
the aqueous phase inhibited the internalization of
w xliposomes by J774 macrophage-like cells 13 . We
also established that they inhibited the internalization
 .of a fluorescent fluid-marker sulforhodamine B SRh .
These results indicated that distribution of PEG-Chols
on the cell surface has reduced not only the binding
of liposomes but also cellular endocytic andror
phagocytic activities.
Mammalian cells, including phagocytes, internal-
ize molecules of great physiological importance by
receptor-mediated clathrin-dependent endocytosis
w x14,15 . Recent results emphasize the existence of
 .clathrin-independent endocytic mechanism s , al-
though more details remain to be elucidated for
w x.review see 16 . However, recent a study suggests
that bulk fluid is internalized either via a clathrin-in-
dependent or via a clathrin-dependent mechanism,
although the ratio between the two routes varied
w xamong cell types 17 . In both cases, the internaliza-
tion of the cell surface is achieved by invagination of
the plasma membrane. This process is suggested to
be accelerated by an increase of the inner leaflet area
w xdue to asymmetric distribution of lipids 18 . In this
model, in the absence of transbilayer movement of
 .phospholipids flip-flop , the mechanical constraints
due to the expansion of the inner monolayer are
proposed to be compensated by membrane invagina-
w xtion 19,20 . It can be assumed that the addition of
PEG-Chol in the outer leaflet would tend to expand
the outer monolayer-half. This action would counter-
act the mechanism used for the endocytic membrane
internalization.
In this paper, we studied the influence of PEG-
Chols on cell membrane dynamics in endocytic pro-
cesses. We measured the internalization of the fluid-
 .phase markers, horseradish peroxidase HRP or SRh
and monitored the clathrin-dependent endocytosis by
 .using EGF and transferrin Tfn ligands, and an
antibody against the Tfn-receptor. We focused on
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PEG-Chols with ns50 and 200, which were previ-
w xously shown to inhibit fluid phase endocytosis 13 ,
knowing that the latter is a good candidate for lipo-
w xsome modification in term as drug-carrier 8 . We
found differential effects of these PEG-Chols on
clathrin-dependent and -independent endocytosis.
2. Materials and methods
2.1. Materials
 . Poly ethylene glycol cholesteryl ethers PEG-
.Chols with average numbers of ethylene glycol units
w xof 50 and 200 8 were kindly provided by Nikko
 .Chemical Co. Tokyo, Japan . The average degree of
polymerization was monitored by the increase in
weight of the reaction mixture. These amphipathic
molecules have the Poisson distribution of ethylene
oxide chain length, but were used without purifica-
tion. 125I-labeled human epidermal growth factor
 .  .EGF and human transferrin Tfn were purchased
 .from Amersham UK . Non-labeled human recombi-
nant EGF or other reagents not specified were ob-
 .tained from Wako Pure Chemicals Osaka, Japan .
2.2. Preparation of fluorescein-labeled PEG-Chol
 .Fluorescein-PEG-Chols FPEG-Chols which con-
tain a fluorescein on the distal end of PEG chain
were synthesized using the following procedure. In
order to obtain fluorescein-labeled PEG-Chol
Cholesterylpolyethyleneglycol resorcinophthalein es-
.ter , we at first prepare mesylate PEG-Chol and then
conjugate fluorescein to it. Methanesulfonyl chloride
 .5 ml was added dropwise to a solution of
 .  .  .PEG 200 -Chol 5.6 g in pyridine 30 ml at 08C.
After being stirred for 10 min, the cooling bath was
removed and the reaction mixture was stirred at room
temperature for 4 h. The reaction mixture was con-
centrated under reduced pressure and extracted with
CHCl . The extract was washed with dilute NaHCO3 3
 .and brine, dried and concentrated. The residue 5.7 g
was subjected to column chromatography on silica
 .gel eluent: MeOHrCHCl , 1r10 . The product elu-3
 .ates were rinsed with Et O to give mesylate 2.3 g2
as colorless powder. A mixture of mesylate PEG-Chol
 .  .  .2.0 g , fluorescein sodium 0.4 g , K CO 0.4 g2 3
 .and DMF 20 ml was heated at 808C for 4 h. The
reaction mixture was concentrated to remove DMF.
 .The residue was extracted with CHCl 350 ml and3
the extract was washed thoroughly with 5% NaHCO3
to remove excess of fluorescein, dried and concen-
trated. The residue was subjected to column chro-
matography on silica gel. The main eluates were
treated on lober column and eluted with a mixture of
 .  .MeOHrCHCl 1r7.5 to give ester 360 mg as an3
orange crystalline powder. Characterization of the
obtained products had been carried out using 1H-NMR
 .270 MHz, CDCl . Intermediate compound, mesy-3
 .  .late PEG 200 -Chol showed d 0.67 s,3H , 0.86
 .  .d,6H, Js6.8 Hz , 0.91 d,3H, Js6.7 Hz , 0.99
 .  .  .s,3H , 3.08 s,3H , 4.38 t,2H, Js4.6 Hz , 5.37
 .  .d,1H, Js4.9 Hz . The final product, FPEG 200 -
 .  .Chol showed d 0.67 s,3H , 0.87 d,6H, Js6.5 Hz ,
 .  . 0.92 d,3H, Js6.8 Hz , 0.99 s,3H , 4.09 t,2H,
.  . Js4.3 Hz , 5.34 d,1H, Js4.9 Hz , 6.64 dd,2H,
.  . Js2.2, 9.2 Hz , 6.73 s,2H , 6.87 d,2H, Js9.2
.  . Hz , 7.31 d,1H, Js7.6 Hz , 7.67 dd,1H, Js7.6,
.  . 7.6 Hz , 7.73 dd,1H, Js7.6 Hz , 8.26 d,1H, Js
.  .7.6 Hz . Rf value of TLC MeOHrCHCl ; 1r7.53
 .was 0.45. FPEG 50 -Chol was prepared by the same
procedure as described above with slight modifica-
 .tions. Intermediate compound, mesylate PEG 50 -
 .  .Chol showed d 0.68 s,3H , 0.86 d,6H, Js6.8 Hz ,
 .  .  .0.91 d,3H, Js6.8 Hz , 0.99 s,3H , 3.09 s,3H ,
 .  .4.37 t,2H, Js4.6 Hz , 5.33 d,1H, Js5.0 Hz .
 .The final product, FPEG 50 -Chol showed d 0.68
 .  . s,3H , 0.86 d,6H, Js6.8 Hz , 0.91 d,3H, Js6.8
.  .  . Hz , 0.99 s,3H , 4.09 t,2H, Js4.5 Hz , 5.33 d,1H,
.  .Js4.9 Hz , 6.66 dd,2H, Js1.6, 9.2 Hz , 6.75
 .  . s,2H , 6.88 d,2H, Js9.2 Hz , 7.32 d,1H, Js7.3
.  . Hz , 7.67 dd,1H, Js7.6, 8.4 Hz , 7.70 dd,1H,
.  .Js7.3, 8.4 Hz , 8.27 d,1H, Js7.6 Hz . Rf value
was 0.40.
2.3. Cell culture
HT-1080 cells were cultured in Dulbecco’s Modi-
 .fied Eagle Medium DMEM, Nissui, Tokyo, Japan
 .supplemented with 10% vrv heat-inactivated fetal
 .bovine serum FBS, Bio-Whittaker, MD USA , 1
 .mM sodium pyruvate, penicillin 100 000 unitsrl
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 .and streptomycin 0.1 mgrml as previously de-
w xscribed 17 . Cells were used after 2 days of culture
for the measurements of endocytic activities.
2.4. Measurement of interaction of fluorescein-PEG-
Chols with cells
Cells in 3 cm Falcon Petri dishes plated 2 days
5 . before at 1.5=10 cells were rinsed with Hepes 5
.  .mM -buffered DMEM Hepes–DMEM with or
 .without 2% vrv serum at 378C for 30 min. They
were incubated with a various concentration of
FPEG-Chols for 30 min at 378C. They were then
washed with ice-cold Hepes buffer 10 mM Hepes,
.137 mM NaCl, 6 mM KCl, 6.1 mM glucose, pH 7.4
4 times and solubilized in 0.5 ml of Hepes buffer
containing 0.2% Triton X-100 at 48C for 1 h. After
centrifugation at 7000=g for 10 min, the super-
natant was analyzed for the fluorescein fluorescence
with excitation and emission wavelengths at 490 nm
and 520 nm, respectively, by using a spectrofluorom-
 .eter RF 5000 Shimadzu, Kyoto, Japan . The results
were presented as nmol of FPEG-Chol associated per
106 cells. Protein content was determined by the
w xmethod of Bradford 21 with human transferrin as a
standard using a microplate reader BioRad model
.450 . Calibration curves of FPEG-Chols had been
drown to allow direct reading of the molecule uptake
from the fluorescence measurement. The influence of
serum lipoproteins on FPEG-Chol interaction with
cells was investigated by using lipoprotein-deficient
 .fetal bovine serum FBS and delipidized human
 .serum Bio-Whittaker . Delipidized human serum was
western-blotted on PVDF membrane Millipore, Bed-
.ford, MA after SDS–PAGE. They were examined
for ApoB by using anti-ApoB monoclonal antibody
 .Boehringer, Germany and ECL-detection
 .Amersham . The amount of lipids in the serum was
quantified by using a lipid-quantitation kit Phos-
.pholipid C-test, Wako Pure Chemicals, Osaka, Japan .
Association of FPEG-Chols with the cells was visual-
ized under confocal microscopy. Cells on a coverslip
were incubated with FPEG-Chol in a humidified
chamber at 308C. After washing, the cells were ob-
served in buffer without fixation by mounting the
coverslips on slide glasses using pieces of parafilm as
spacers. Cells were observed under a confocal laser
 .scanning system MRC-600, Biorad, Hercules, CA
coupled with an Axiophoto microscope Carl Zeiss,
.Germany at 258C.
2.5. Treatment of cells with PEG-Chols and measure-
ment of fluid-phase internalization
 5 .Cells grown 1.5=10 cells in 3 cm dishes
 .Falcon, USA for 2 days were preincubated with
 .PEG-Chols at 0.1–10 mM in Hepes–DMEM 1 ml
for 30 min at 378C. The dishes were placed in a
humidified chamber in a shaking incubator. Measure-
ment of fluid phase endocytosis was performed by
adding HRP at 1 mgrml in the medium. Then, at
time intervals, cells were washed with ice-cold PBS
 .145 mM NaCl, 10 mM Na phosphate, pH 7.2 3
times and scraped into Eppendorf tubes and washed
with PBS 3 times by centrifugation at 3000=g at
48C for 5 min. The washed cells were solubilized in
0.45 ml of TBS 150 mM NaCl, 50 mM Tris–HCl,
.pH 8.0 containing 0.2% Triton X-100 and 10 mM
 .p-amidinophenyl methanesulfonyl fluoride hydro-
 .chloride APMSF , at 48C for 1 h. After centrifuga-
tion at 10 000=g for 10 min, the supernatant was
w xanalyzed for protein content 21 and peroxidase ac-
tivity using tetramethylbenzidine as a substrate. The
results were normalized on cellular protein content.
Temperature dependence of HRP uptake was mea-
sured by incubating cells at various temperature for
 .30 min after pretreatment with 2.5 mM PEG 50 -
Chol, followed by addition of HRP for 5 min.
2.6. Measurement of internalization of EGF, Tfn and
anti Tfn-receptor antibody
 5 .Cells plated 2 days before at 1.5=10 cells were
pretreated with various concentration of PEG-Chols
as described above. For the measurement of EGF
internalization, cells were incubated in Hepes–
DMEM containing 2% dialyzed FBS, 5 ngrml non-
labeled EGF and 1.85 kBqrml 125I-EGF at 378C in
the presence of the same amount of PEG-Chol as in
the pretreatment. Cells were washed 6 times with
ice-cold Hepes–DMEM. The radioactivity that re-
mained on the cell surface was recovered by treating
the cells with DMEM pH 3.0 at 48C for 2 min.
Internalized radioactivity was recovered by solubiliz-
ing cells in 2=0.5 ml of 1 N NaOH after the acidic
treatment. The radioactivity was determined in a
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Clinigamma counter Pharmacia LKB, Uppsala, Swe-
.den . In order to monitor the intracellular degradation
of the ligand, PEG-Chol-treated cells were first incu-
bated with 5 ng EGFr125I-EGF in 1 ml of Hepes–
DMEM–2% FBS at 378C for 10 min. Cells were then
washed with Hepes–DMEM at 378C and chased in 2
ml of Hepes–DMEM–2% FBS at 378C in the pres-
ence of PEG-Chol. At time intervals, 200 ml of the
medium was collected and treated with trichloro-
 .acetic acid TCA with a final concentration of 20%.
After incubation on ice for 30 min, the samples were
centrifuged at 10 000=g for 5 min and the TCA-
soluble radioactivity was measured.
For the measurements of Tfn uptake, cells were
first incubated in serum-free DMEM for 1 h at 378C,
then with PEG-Chol in serum-free DMEM for 30
min. Then cells were incubated in 1 ml of serum-free
DMEM containing 0.5 mgrml of non-labeled Tfn
and 1.85 kBqrml of 125I-Tfn in the presence of
PEG-Chol. At different time intervals, cells were
washed, acid-treated and solubilized in 1 N NaOH.
For the measurement of Tfn-receptor internalization,
cells were incubated with FITC-labeled anti-human
 .Tfn receptor antibody Pharmigen, San Diego, CA in
2% FBS–DMEM at 378C. At intervals, cells were
washed twice with ice-cold DMEM, 3 times with
PBS, and solubilized in 0.45 ml of TBS containing
0.2% Triton X-100. After centrifugation at 10 000=g
for 10 min, the supernatant was analyzed for protein
and for FITC fluorescence.
3. Results
3.1. Distribution of PEG-Chols in HT-1080 cells
We previously found that incubation of a murine
macrophage-like cell line J774 with free PEG-Chol
reduced the internalization of liposomes and SRh, a
w xfluid-phase marker 13 . In order to discriminate the
effects of our amphipathic molecules on phagocytic
and endocytic process, we studied the action of
PEG-Chol on a human fibrosarcoma cell line HT-
1080. HT-1080 cells were previously shown to inter-
nalize a large amount of fluid phase by both
clathrin-dependent and -independent mechanisms
w x22 . The cells, however, did not internalize heat-in-
activated yeast S. cere˝isiae or fluorescent zymozan
particles through phagocytosis, as macrophage-like
J774 cells. Preliminary results also indicate that bind-
ing and internalization of liposomes prepared from
egg phosphatidylcholine were very low in HT-1080
 .Ishiwata et al., unpublished data .
We first tested the distribution of the PEG-Chols
in HT-1080 cells using fluorescent derivatives of the
 .amphipathic molecules FPEG-Chols . The molecules
contained a single fluorescein at the distal end of the
PEG moiety, thus could be used as a good analog of
the mother molecule. A test had been carried out to
seek the action at cellular level of the fluorescent
 . derivatives data not shown . Cells on coverslips ca.
4 .2=10 cells were incubated with 100 ml of 0.5 mM
 .FPEG 200 -Chol in Hepes–DMEM–2% FBS at 308C
for 30 min. Fig. 2 shows typical confocal fluores-
 .cence images of the cells at the upper surface left
 .and inside the cell right . As one can see, strong
fluorescence was detected not only on the cell surface
but also in intracellular vesicles. A similar result was
 .obtained with FPEG 50 -Chol at 2.5 mM. During the
observation, these fluorescent vesicular structures lo-
calized at first in the cell periphery slowly moved
toward the nucleus, suggesting that they were related
 .to the endocytic compartments data not shown .
Total association of FPEG-Chols to the cells was
quantified by measuring the fluorescence intensity
after their solubilization. When cells in a dish were
incubated with an increasing concentration of FPEG-
Chol at 378C for 30 min, the cell-associated fluores-
 .cence increased linearly Fig. 3 . The critical micelle
 .  .concentrations, of PEG 50 -Chol and PEG 200 -Chol
at 378C in Hepes buffer were determined by turbido-
w xmetric analysis as described by Uster et al. 23 .
 .Values were 0.5"0.3 mM unpublished results ,
which is in the range of the values obtained in pure
water by the Du Nouy method, a more sensitive¨
w xtechnique 8 . The lack of saturation was in contrast
to the previous results showing a rapid saturation of
the PEG-Chol association to liposomal membranes
w x8 . This was probably because the replenishment of
plasma membrane, by a combination of the steady
endocytic and exocytic process in the living cells,
continued to provide the non-saturable binding sites
for FPEG-Chols. Knowing the area occupied per
w xmolecule 8 , the surface occupied by PEG-Chols on
the cell can be estimated. It would be over 1.5% of
the apical surface area if 0.1 nmol of PEG-Chols is
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 .Fig. 2. HT-1080 cells were observed under confocal microscopy, after incubation with 0.5 mM Fluorescein-PEG 200 -Chol for 30 min at
 .  .308C. Fluorescence of FPEG-Chol was distributed to cell surface uniformly left and into vesicles inside cell right . Bar: 25 mm.
localized only on the apical surfaces of 106 cells. The
efficiency of distribution between medium and cells
 .was 2-fold higher for FPEG 50 -Chol, suggesting an
involvement of the steric effect of the PEG moiety on
the insertion of cholesteryl part andror on the stabi-
lization of membrane-bound state. It is interesting to
recall that measurement of the depolarization factor
 .r of diphenyhexatriene fluorescence in egg PC lipo-
 .somes 200 nm in diameter showed an increase in
the order of the hydrophobic membrane core in the
presence of PEG-Chol control; r s 0.079,
 . .PEG 200 -Chol; rs0.085 . These values were lower
than that in egg PC liposomes containing 25%
 . w xmolrmol of Chol 8 .
Regardless of the length of the PEG moiety, the
uptake of FPEG-Chols by cells was markedly en-
 .hanced when removing the serum Fig. 3 . An in-
crease of cell uptake was observed when using serum
free of lipoprotein particles compared to complete
serum, suggesting that they provided competitive
binding sites for the cholesteryl moiety of PEG-Chols
 .Table 1 .
3.2. PEG-Chols inhibit fluid phase endocytosis re-
gardless of the length of PEG
Internalization of fluid phase components was
measured by using a non-specific marker, horseradish
 .peroxidase HRP . We assessed the activity in the
presence of 2% FBS. HRP does not bind to the cell
surface at 48C and is, therefore, considered as a fluid
phase marker not as a marker of adsorptive pinocyto-
 .sis data not shown . The internalized fluid phase was
0.060 mlrhr106 cells, which is comparable to previ-
w xously reported results 17 . When cells were preincu-
 .bated with PEG 50 -Chol, internalization of HRP was
markedly reduced representing about 40% of control
 .at 2.5 mM after 30 min Fig. 4 . The effect was
observed even at the early time point assessed Fig.
.4A . Apparent efficiency of inhibition was higher for
 .PEG 50 -Chol but, when the result was normalized
by the PEG-Chol amount associated to the cells
Fig. 3. Fluorescein-PEG-Chol accumulation in cells was deter-
mined by incubation in Hepes–DMEM containing 2% FBS
 .  .filled or serum-free Hepes–DMEM open for 30 min at 378C.
After incubation, cells were washed with Hepes buffer 4 times
and then dissolved in 0.2% Triton X-100. After centrifugation at
10 000 rpm for 10 min, supernatant was analyzed for protein
amount and fluorescence intensity with excitation and emission
wavelength of 490 and 520 nm, respectively. The results were
represented as nmol of FPEG-Chol associated with 106 cells"
S.E.; protein amount of 106 cells was 0.233 mg. Accumulated
 .  .amount of FPEG 50 -Chol e, l was larger than that of
 .  .FPEG 200 -Chol ^, ’ .
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Table 1
Influence of serum and lipoproteins on PEG-Chol association to cells.
Serum free FBS Lipoprotein-deficient Human serum Human serum
FBS delipidized
Serum characterization
 .Protein amount mgrml – 26.8 18.2 52.5 40.2
 .Phospholipid mgrml – 0.429 0.088 1.970 0.110
Human apoB detection – y y qqq q
Fluorescein-PEG-Chol association
 .FPEG 50 -Chol, 2.5 mM 0.730"0.048 0.293"0.024 0.405"0.028 0.163"0.020 0.426"0.028
6 .nmolr10 cells
 .FPEG 200 -Chol, 2.5 mM 0.339"0.018 0.169"0.015 0.243"0.036 0.070"0.005 0.212"0.010
6 .nmolr10 cells
Phospholipid amount as lipoprotein amount in each serum used here was quantified by using a lipid-quantitation kit Phospholipid C-test
.Wako . Serum protein amount was determined by method of Bradford. Each serum was Western-blotted on PVDF membrane after
SDS–PAGE. They were examined for apoB by using anti-apoB monoclonal antibody and ECL-detection. FPEG-Chol association to cells
was shown as nmol of FPEG-Chol associated to 106 cells"S.E. The procedure was described in Fig. 3 and more precisely in text.
 .  .FPEG 50 -Chol and FPEG 200 -Chol showed similar dependence on serum type.
estimated from the curves presented in Fig. 3, no
 .difference could be detected Fig. 4B . Interestingly,
the concentration-dependence of the inhibition was
 .biphasic Fig. 4B with a sharp decrease observed up
to 0.2 nmolr106 cells, the reduction of the internal-
ization represented 30% of the whole activity per 0.1
nmol PEG-Cholr106 cells. In contrast, when cell-as-
sociated PEG-Chol exceeded 0.2 nmolr106 cells, the
reduction was less than 3% per 0.1 nmol PEG-
Cholr106 cells. This inhibitory effect showed some
saturation at about 20% of the total activity. Increase
in the applied concentration of PEG-Chols induced
an extensive cell rounding, then detachment from the
plates. Continuous presence of PEG-Chol at 2.5 mM
 .5 nmolr100 cells, in 2 ml in the growing medium
had no effect on the size and number of colonies
determined after 1 week of culture, indicating that in
our conditions, the amphipathic molecules were not
toxic.
3.3. Effect of PEG-Chols on the receptor-mediated
internalization of EGF
In contrast to the marked effect on the fluid phase
 .endocytosis, PEG 50 -Chol did not inhibit receptor-
mediated endocytosis of EGF. Cell-associated EGF
 .amount for PEG 50 -Chol-treated cells was similar to
 .that of untreated control cells Fig. 5 . Cells were
briefly treated with a medium at pH 3.0 at 08 C, after
incubation with 125I-EGF at 378C. Treatment at low
pH removes the ligands that remained bound on the
cell surface. This amount of releasable radioactivity
 .was larger for PEG 50 -Chol-treated cells after 10
min incubation than that in control cells, although the
 .non-releasable radioactivity was identical Fig. 6A .
Binding of the ligand at 48C, which can be inhibited
by the presence of non-labeled EGF in excess, was
 .2.5-fold higher for cells pretreated with PEG 50 -Chol
 .at 378C data not shown . These two results indicate
 .that PEG 50 -Chol has an effect on the binding but
not on the subsequent internalization of EGF. There-
 .fore, it appeared that presence of PEG 50 -Chols in
the plasma membrane may increase the number of
receptors on cell surfaces andror increase the affinity
of ligand for its receptor. It had been shown that
some of internalized EGF receptors were recycled to
w xthe cell surface 24,25 . The number of receptors on
the surfaces of PEG-Chol-treated cells could be in-
creased by a partial inhibition of the clathrin-indepen-
dent endocytic process.
Clathrin-dependent internalization of ligand-recep-
tor complexes consists of at least three distinct steps,
e.g. coated pit invagination, membrane constriction,
w xrelease of coated vesicle by fission 26,27 . The
 .above results indicated that PEG 50 -Chol did not
interfere with the first two steps. In order to assess
the effect on the final step, cells pretreated with 2.5
 .mM PEG 50 -Chol were incubated with 5 ngrml
125I-EGF for 30 min and chased for 3 h. The kinetics
of generation of TCA-soluble radioactivity that re-
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 .Fig. 4. A Kinetics of HRP uptake at 378C was investigated with
 .  .control cells ‘ and cells treated with 2.5 mM PEG 50 -Chol
 .l . Cells were incubated in 2% FBS–Hepes–DMEM contain-
ing 1 mgrml HRP. At intervals, cells were washed with ice-cold
 .PBS - and scraped into Eppendorf tubes. Washed cells were
solubilized in 0.2% Triton X-100. After centrifugation at 10000
= g for 10 min, the supernatant was analyzed for protein and the
peroxidase activity using tetramethylbenzidine as a substrate. The
 .results were normalized for cellular protein. B Decrease of HRP
uptake by PEG-Chol treatment was determined after 15 min
incubation at 378C. This decrease depended on PEG-Chol amount
in cells, calculated from concentration in medium using standard
curves described in Fig. 3. The results were expressed as the
 .  .mean"S.E. No difference between PEG 50 -Chol l and
 .  .PEG 200 -Chol ’ was observed. The activity of control cells
 . 6‘ was about 0.060 mlrh r10 cells. This inhibition depen-
 .dence showed 2 phases dotted lines , which implied that cells
had 2 pathways for HRP uptake; one was the PEG-Chol-sensitive
route and the other the insensitive route.
flect the EGF degradation within lysosomes was
 .identical to that of control cells Fig. 6B . These
 .results indicate that PEG 50 -Chol has no effect on
the final step of coated vesicle-formation and the
subsequent transport to lysosomes.
 .The effect of PEG 200 -Chol was very similar to
 .that of PEG 50 -Chol, except that it reduced the
cell-associated amount by 20% at a higher concentra-
 .tion Fig. 5 . However, the treatment did not change
the subsequent steps since the kinetics of generation
of radioactivity not releasable at low pH were similar
to those in control cells. Generation of TCA-soluble
radioactivity was also very similar with or without
 .  .PEG 200 -Chol treatment Fig. 6 . These results sug-
 .gest that association of PEG 200 -Chol slightly re-
duces the binding of the ligand to the receptor but
does not influence the formation and internalization
of coated vesicles. Pretreatment at 378C with
 .PEG 200 -Chol also increases the ligand binding at
 . low temperature by 2.5 as with PEG 50 -Chol data
.not shown .
( )3.4. PEG 200 -Chol inhibits the internalization of Tfn
ligand but not the receptor
We next studied the effect of PEG-Chols on the
 .internalization of transferrin Tfn . Most of the Tfn
receptors are constitutively internalized and recycled.
They are known to be already clustered in clathrin
w xlattice 28,29 . Before the measurement, cells were
depleted of the intrinsic ligand by incubation in a
serum-free medium for 1 to 3 h. Nevertheless, mea-
surement of binding of 125I-Tfn at 48C indicated that
only 400 ligand-binding sites for one cell were avail-
able. This represents a very low number of receptor
Fig. 5. Dependence of EGF uptake on PEG-Chol amount in cells
was investigated. PEG-Chol amount in cells was calculated from
concentration in medium using standard curves described in Fig.
3. Cells were incubated for 20 min in Hepes–DMEM containing
2% dialyzed FBS, 5 ngrml non-labeled EGF and 1.85 kBqrml
125I-EGF at 378C. After incubation, cells were washed, acid-
treated and then cell-associated radioactivity was recovered in 1
N NaOH. The results were normalized for cellular protein and
represented as relative amount"S.E. to the control cells. Inter-
 . 6nalized amount of control cells ‘ was 0.17 ngr10 cells.
 .  .PEG 50 -Chol treatment l induced little effect on EGF uptake;
 .  .20% decrease was observed with PEG 200 -Chol treatment ’ .
( )H. Ishiwata et al.rBiochimica et Biophysica Acta 1359 1997 123–135 131
 .Fig. 6. A Kinetics of EGF uptake was investigated with control
 .  .  .cells v, ‘ , 2.5 mM PEG 50 -Chol e, l - and 0.5 mM
 .  .PEG 200 -Chol ^, ’ - treated cells. Cells were incubated in
Hepes–DMEM containing 2% dialyzed FBS, 5 ngrml non-
labeled EGF and 1.85 kBqrml 125I-EGF at 378C. After incuba-
tion, cells were washed, acid-treated and then cell-associated
 .radioactivity filled symbols was recovered in 1 N NaOH.
Radioactivity in acid fraction was also analyzed as surface-bound
 .amount open symbols . The results were normalized for cellular
 .protein and represented as relative amount"S.E. B PEG-Chol
influence on lysosomal degradation and exocytosis of associated
EGF was investigated to confirm clathrin-coated vesicle budding
in PEG-Chol-treated cells. The cells, which loaded with 5 ngrml
EGFr125I-EGF in Hepes–DMEM–2% FBS for 10 min at 378C,
were chased for 3 h. At intervals, TCA-soluble count from
medium was measured. The results were expressed as the mean
 .  ."S.E. The cells treated with 2.5 mM PEG 50 -Chol l as well
 .  .as 0.5 mM PEG 200 -Chol ’ showed similar recovery to
 .control cells ‘ .
available since A431 cells for example, had about
1.2=105 Tfn binding sites per cell on their surfaces
w x28 , a number which is about 3 thousand times
higher than that for the HT-1080 cell. Even under this
condition, HT-1080 cells readily internalized as much
as 5.6 ng Tfn per 106 cells in 30 min. Indeed in this
case, the amount of the ligand releasable by the
treatment at low pH was very small less than 0.3 ng
6 .per 10 cells . Most of the Tfn-receptors were dis-
tributed in the intracellular vesicles as can be ob-
served under microscope by immunofluorescence
 .data not shown . These results suggest that even if a
very small fraction of Tfn-receptors was on the sur-
face of HT-1080 cells, it was sufficient to internalize
a large amount of extracellular ligands. A rapid
turnover of the receptor between the surface and the
w xintracellular vesicular pool 28 consistently accounts
for the efficient internalization of the ligand in the
cells.
 .When cells were treated with PEG 50 -Chol, inter-
nalization of Tfn was as little affected as EGF Table
.2 . In contrast, the decrease of ligand–receptor com-
 .plex uptake in presence of PEG 200 -Chol was much
stronger. Incubation of cells with 0.1 mM
 .PEG 200 -Chol in a serum-free medium was enough
to inhibit up to 50% of the Tfn-uptake. As described
above, the total amount of PEG-Chols associated
with the cells is larger if incubation is carried out in a
serum-free medium rather than in a serum-containing
one. Indeed, in the presence of 2% serum, the exter-
nal concentration had to be 3 times higher to obtain
the same amount of associated amphipathic molecules
to cells than in serum-free medium. For an incubation
 .with PEG 200 -Chol at 0.1 mM in serum-free
medium, the cell-associated amount was 0.024 nmol
per 106 cells. However at this amount in cells, inter-
nalization of EGF or HRP was reduced slightly.
In contrast to the marked effect on the internaliza-
tion of Tfn, the uptake of the fluorescent monoclonal
antibody bound to the receptor was little affected by
the presence of PEG-Chols in the cell plasma mem-
brane. The assay was carried out in the presence of
2% FBS in order to avoid the non-specific associa-
tion of the antibody to cells and to plastic substrate.
 .We used PEG 200 -Chol at a concentration of 0.5
mM for 1 h, knowing that, in the same conditions,
0.032 nmolr106 cells of FPEG-Chol interact with the
cells. This amount was more than 50% in the pres-
 .ence of 0.1 mM PEG 200 -Chol in serum-free
DMEM. However, even under this condition, we
 .observed no effect of PEG 200 -Chol on the antibody
 .internalization Table 2 . The localization of the fluo-
rescent antibody in endosomes was confirmed by
 .fluorescence microscopy data not shown .
Taken together, these results strongly suggest that,
 .although PEG 200 -Chol interferes with the interac-
tion between ligand and receptor, the distribution of
PEG-Chols does not influence the internalization of
clathrin-coated pits.
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Table 2
 .  .Difference between PEG 50 -Chol and PEG 200 -Chol on ligand uptake.
 .  .PEG-Chol treatment PEG 200 -Chol PEG 50 -Chol
0.1 mM 0.5 mM 2.5 mM
6 .FPEG-Chol association in FBS-free DMEM nmolr10 cells 0.024"0.001 0.107"0.004 0.730"0.048
 .Transferrin uptake % of control 51.2"5.3 24.5"2.9 96.1"20.5
6 .FPEG-Chol association in 2% FBS–DMEM nmolr10 cells 0.005"0.000 0.032"0.002 0.353"0.017
 .Transferrin receptor antibody uptake % of control – 91.1"6.4 99.8"6.8
Tfn uptake by cells was performed after depletion of cellular Tfn. Cells were then incubated in serum-free DMEM containing 0.5 mgrml
non-labeled Tfn and 1.85 kBqrml 125I-Tfn for 30 min. After incubation, cells were washed, acid-treated and then cell-associated
 .radioactivity was recovered in 1 N NaOH. FITC-labeled human Tfn receptor antibody CD71 , was incubated with cells in 2% FBS–
DMEM at 37qC for 1 h. Associated CD71 amount was determined from FITC fluorescence, measured with excitation and emission
wavelength at 495 nm and 520 nm, respectively. Internalized amount was estimated by subtraction of surface bound amount, measured by
incubation on ice. HRP uptake was determined by 30 min incubation in 2% FBS–DMEM. These results were normalized for cellular
protein and represented as percentages"S.E. to the control cells
3.5. Temperature-dependence of PEG-Chol-sensiti˝e
endocytosis is similar to that of clathrin-dependent
endocytosis
The presence of a PEG-Chol-sensitive internaliza-
tion of the bulk fluid led us to estimate the difference
in the highest activation energy of PEG-Chol-sensi-
tive and -insensitive endocytosis. We measured the
internalization of HRP in the presence and absence of
 .2.5 mM PEG 50 -Chol. The amount of PEG-Chol in
6  .the cells would be 0.4 nmol per 10 cells see Fig. 3 .
At this concentration, cells were assumed to have no
 .Fig. 7. Arrhenius plot was measured with control cells ‘ and
 .  .cells treated with PEG 50 -Chol at 2.5 mM l , and was deter-
mined by subtracting associated HRP amount in PEG-Chol-treated
 .cells from that in control cells, as PEG-Chol-sensitive route =
to know difference of activation energy between PEG-Chol-sensi-
tive and -insensitive route. HRP uptake was investigated by 5
min incubation at several temperature points. Activation energy
of PEG-Chol-sensitive route was similar to that of PEG-Chol-in-
sensitive route.
clathrin-independent endocytosis. We applied the
marker for only 5 min to be able to observe the
temperature effect on the early events. Arrhenius plot
 .of the rate of internalization of the marker Fig. 7
indicated that the two slopes obtained in the absence
or presence of PEG-Chol were highly similar. If the
clathrin-dependent internalization of the fluid phase
corresponded to that at cell-associated PEG-Chol su-
6  .perior to 0.35 nmol per 10 cells see Fig. 4B ,
PEG-Chol-sensitive activity could be obtained by
subtraction of the activity measured in the presence
of 2.5 mM PEG-Chol from the one measured in
untreated cells. The slope of this fraction was also
very similar in the Arrhenius plot. These results
imply that activation energies that are required to
overcome the highest barrier in the clathrin-depen-
dent and PEG-sensitive endocytosis were similar.
4. Discussion
We had previously shown that PEG-Chols drasti-
cally reduce the internalization of liposomes and
fluorescence fluid marker, sulforhodamine B, in a
w xmacrophage-like cell line J774 13 . In the present
study, we prepared fluorescent PEG-Chols with fluo-
rescein moiety conjugated at the distal end of the
PEG-part. Observation under a confocal laser scan-
ning microscope indicated that the molecules in aque-
ous suspension distributed to both plasma membrane
surface and intracellular vesicles. Quantitation of flu-
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orescence intensity indicated that the total association
of amphipathic molecules to the cells was reduced in
the presence of serum in the incubating medium
 .Table 1 . The critical micelle concentration of
 .  .PEG 50 - and PEG 200 -Chols in Hepes buffer are
 .0.5"0.3 mM Ishiwata et al., unpublished result .
However, FPEG-Chol association to the cells did not
change over the critical micelle concentration indicat-
ing that the presence of micelle form is of little
importance in the course of PEG-Chol interactions
 .with the cells Fig. 3 . We did not observe punctuate
fluorescence on the cell surface and in the vesicles.
The marked reduction of the serum-effect obtained
by the depletion of lipoprotein particles suggests that
the hydrophobic lipid core competed with the inser-
tion of cholesteryl moiety in the membrane. This
result also suggests that internalization of FPEG-
Chol-containing lipoprotein particles by receptor-
mediated endocytosis did not contribute in the accu-
mulation of FPEG-Chols in HT-1080 cells.
The presence of fluorescent vesicular structures in
cells incubated with FPEG-Chols suggests that endo-
cytic internalization of surface membrane is not abol-
ished by the amphipathic molecules. The lack of the
 .saturation of cell-associated FPEG-Chol Fig. 3 im-
plied that the replenishment of surface binding sites
for the amphipathic molecules by a combination of
endocytic and exocytic process may be responsible.
 .  .Nonetheless, both PEG 50 - and PEG 200 -Chols
drastically reduced the internalization of fluid phase
 .Fig. 4 . The degree of inhibition was dependent on
the amount of cell-associated amphipathic molecules.
These results suggest that insertion of the cholesteryl
moiety that would not move across the hydrophobic
membrane core by flip-flop, due to the bulky and
hydrophilic PEG moiety, inhibited this fluid phase
endocytosis. In contrast, receptor-mediated internal-
ization of EGF and Tfn was little influenced by
 .PEG 50 -Chol. The generation of TCA-soluble ra-
125  .dioactivity by the chase of I-EGF Fig. 6B indi-
 .cated that PEG 50 -Chol neither inhibit the coated
budding nor the subsequent endosomal transport to-
 .ward lysosomes. Treatment with PEG 200 -Chol re-
duced the internalization of Tfn but it did not inhibit
that of the anti-receptor antibody. These results sug-
gest that both PEG-Chols had no effects on the
clathrin-dependent internalization of membrane, while
 .PEG 200 -Chol interfered with the binding of ligand
to its receptor. One big difference between the two
ligands used in this study is that EGF is a peptide of
6 kDa molecular weight, while Tfn is a 75 kDa
macromolecule, indicating a drastic difference in their
size and steric environment. However, these factors
do not seem to be of great importance since the
receptor-mediated endocytosis of Tfn-receptor anti-
bodies, which are even larger macromolecules, were
not affected by the presence of PEG-Chols. Whether
 .the long PEG chain of PEG 200 -Chol curtailed the
accessibility of the ligands to the receptors or reduced
the conformational flexibility of receptor remains to
be elucidated. The first possibility is indicated by the
report describing that coating the liposomes with
PEG inhibited the protein binding to their surfaces
w x30,31 . The second hypothesis is suggested by a
general effect of PEG inducing spontaneous water-
soluble protein precipitation by way of excluded vol-
w xume mechanism 32 . It is a well known fact nowa-
days that liposomes of various composition were
taken up by macrophages in vivo after intravenous
injection. However, PEG-modified liposome showed
interesting hindrance to macrophage uptake because
of the PEG molecules at the liposome surface, intro-
ducing a steric barrier, which would inhibit the lipo-
some binding to the cell and further internalization
w x13,33 . If PEG-Chol molecules were transferred to
cell surfaces from liposomes, they could induce an
interference in liposome binding similar to the case
of Tfn. Moreover, it had already been shown that at
high molar ratio, PEG-Chols were not totally incor-
porated in the liposomes leaving some molecules in
w xthe external aqueous phase 8 , which in turn may
interact with the cell plasma membrane introducing
similar behavior. Opsonins accelerated liposome up-
take by cells by coating them and transforming lipo-
somes into a recognizable entity for specific receptors
w x34 , but PEG-Chol at cell surface could also interfere
with liposomal opsonin-receptor interaction.
When cells were treated with an increasing con-
centration of PEG-Chols, the internalization of HRP
decreased in a dose-dependent manner up to 20% of
the total. The result suggests that distribution of
PEG-Chols reduced the membrane dynamics essen-
tial for clathrin-independent invagination of mem-
brane. Different models of membrane changes in-
duced by the inclusion of PEG-Chol may be pro-
posed such as an orientational defect leading to local
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lipid chain tilting or followed by relaxation of the
elastic stress either by creating local curvature or by
w xthe accumulation of solutes locally 35 . Early study
w xby Gabriel and Roberts 36 showed that addition of
micelles of PC containing short acyl chain induced
the spontaneous formation of unilamellar vesicles
from multilamellar liposomes composed of long-chain
w xPC 36 . More recently, authors had shown that spe-
cific depletion of lysoPC from outer leaflet of a giant
liposome composed of egg PC and lysoPC induced
membrane invagination with the formation of stoma-
w xcyte-like vesicles 19 . Moreover, external addition of
LysoPC to multilamellar giant liposomes induced
drastic changes starting with the creation of ripples at
the liposome surface then subsequently transformed
into multiple protrusions and eventually small vesi-
cles separated out. These findings had been inter-
preted to be due to the surface increase of the exter-
nal leaflet accompanied by the creation of a surface
w xtension 19 . Eventually, on living cells, one can
suppose that introducing such surface tension would
in due course inhibit the creation of the membrane
invagination, and, therefore, the clathrin-independent
endocytosis. It is interesting to note that preliminary
experiments let us show that addition of external
LysoPC, to either J774 macrophages or HT-1080
fibroblasts, induce a drastic inhibition of the fluid
 .phase endocytosis of SRh unpublished results . Initi-
ation of shape changes by low pH-induced transmem-
brane movement of PG in smaller liposomes has also
been demonstrated using cryo-electron microscopy
w x w x37 . Devaux 18 has suggested that expansion of the
inner monolayer of plasma membrane by accumula-
tion of aminophospholipid would participate in the
generation of concave curvature in the cell. More-
w xover, Farge 25 has demonstrated that exogenously
added phosphatidylserine, which was quickly trans-
ported across the membrane by the ATP-dependent
translocase, increased the endocytic membrane inter-
nalization by the generation of a transmembrane sur-
face area asymmetry in the plasma membrane bilayer.
Our results can also be explained according to this
model in which expansion of the outer monolayer by
insertion of cholesteryl moiety of PEG-Chols coun-
teracts the membrane invagination process. The re-
sults further suggest that invagination due to the
generation of membrane curvature by spherical as-
sembly of clathrin triskelions can overcome such
energetic constrains. It has also been shown that
reducing the flexibility of phospholipid acyl chains
decreases the bending of phospholipid bilayers see
w x.35 . However, in our case, the higher depolarization
of DPH recorded in PEG-Chol-containing liposomes
compared to control membranes containing Chol in-
dicates that changes in the flexibility of acyl chains in
the hydrophobic part of the membranes is not likely
to be the cause of the inhibition of the endocytosis.
While PEG-Chols had different effects on
clathrin-dependent and -independent endocytosis, the
two mechanisms showed similar temperature-depen-
 .dence Fig. 7 . From the mechanical point of view,
separation of the connected vesicular part of the
plasma membrane appears to be the highest energy
barrier in the endocytic process. In the case of giant
liposomes, the expansion of outer monolayer induced
the formation of a series of connected small vesicles
w xwhich were not released free 19 . These facts suggest
that the fission process requires a specific mecha-
nism. In clathrin-dependent endocytosis, polymeriza-
tion of the triskelions is known to be insufficient for
vesicle bud formation. The process appears to be
completed by the intervention of dynamin, a large
w xGTP-binding protein 27 . The GTP-bound form of
the protein is structured into a helical structure that
w xseems to constrict the fission site 38,39 . The over-
expression of a mutant dynamin that lacks GTP-bind-
ing does not have any effects on the clathrin lattice
structure formation, but receptor-mediated endocyto-
w xsis of both Tfn and EGF ligands were inhibited 27 .
The similarity observed in the slopes of the Arrhenius
plot implies that energetic constraint in clathrin-inde-
pendent budding is comparable to clathrin-dependent
budding. Whether it is identical to the dynamin-medi-
ated process or a distinctive one is an interesting
subject for further study. Noteworthy is the recent
report of the presence of multiple dynamin-like
molecules in the cytoplasm and on the intracellular
membranes, indicating that another type of dynamin-
like molecules may be involved in clathrin-indepen-
w xdent endocytosis 40 .
This new finding in the PEG-Chol properties con-
firmed their place as extremely good candidates for
the preparation of long life liposomes as drug carri-
ers. Indeed, the main purpose of this new generation
of sterically stabilized liposome is to avoid the retic-
uloendothelial system as much as possible giving
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time to target specific body area. The double activity
of the PEG-Chol molecules, one at the liposome level
by the coating with a hydrophilic and steric barrier,
and the other at the cellular level by reducing the
endocytic process, enhance significantly the possibil-
ity of liposomes to have, in vivo, long circulation
time. Still, more properties have to be elucidated on
the cellular action of these amphipathic molecules, in
particular their effects at phagocytic level. Finally,
this study emphasizes the different needs in the steps
of specific and non-specific endocytic process with
their energy dependency.
References
w x1 K.R. Patel, M.P. Li, J.R. Schuh, J.D. Baldeschwieler,
 .Biochim. Biophys. Acta 797 1984 20–26.
w x2 K. Miyajima, T. Lee, M. Nakagaki, Chem. Pharm. Bull. 32
 .1984 3670–3673.
w x3 K. Miyajima, T. Baba, M. Nakagaki, Colloid Polym. Sci.
 .265 1987 943–949.
w x4 K. Miyajima, T. Baba, M. Nakagaki, Colloid Polym. Sci.
 .267 1989 201–208.
w x5 C. Tasset, F. Goethals, V. Preat, M. Roland, Int. J. Pharm.
 .58 1990 41–48.
w x6 J.M. Franz, J.P. Vonderscher, J. Pharm. Pharmacol. 33
 .1981 565–568.
w x7 J. Drewe, G. Fricker, J. Vonderscher, C. Beglinger, Br. J.
 .Pharmacol. 108 1993 298–303.
w x8 H. Ishiwata, A. Vertut-Doı, T. Hirose, K. Miyazima, Chem.¨
 .Pharm. Bull. 43 1995 1005–1011.
w x9 B.Y. Zaslavesky, N.N. Ossipov, V.S. Krivich, L.P. Bahold-
 .ina, S.V. Rogozhin, Biochim. Biophys. Acta 507 1978
1–7.
w x10 M. Fukuda, M. Koide, K. Ohbu, J. Jpn. Oil Chem. Soc. 36
 .1987 576–580.
w x11 N. Watrous-Peltier, J. Uhl, V. Steel, L. Brophy, E.
 .Merisko-Liversidge, Pharm. Res. 9 1992 1177–1183.
w x12 S. Rudt, H. Wesemeyer, R.H. Muller, J. Controlled Release¨
 .25 1993 123–132.
w x13 A. Vertut-Doı, H. Ishiwata, K. Miyajima, Biochim. Bio-¨
 .phys. Acta 1278 1996 19–28.
w x14 J.L. Goldstein, M.S. Brown, R.G.W. Anderson, D.W. Rus-
 .sell, W.J. Schneider, Annu. Rev. Cell Biol. 1 1985 1–39.
w x  .15 P.J. Courtoy, in: C.J. Steer, J.A. Hanover Eds. , Intracellu-
lar Trafficking of Proteins, Cambridge University Press,
London, 1991, pp. 103–156.
w x  .16 C. Lamaze, S.L. Schmid, Curr. Opin. Cell Biol. 7 1995
573–580.
w x17 S.B. Sato, K. Kiyosue, T. Taguchi, M. Kasai, S. Toyama, J.
 .Cellular Physiology 166 1996 66–75.
w x  .18 P.F. Devaux, Biochemistry 30 1991 1163–1173.
w x  .19 E. Farge, P.F. Devaux, Biophys. J. 61 1992 347–357.
w x  .20 E. Farge, Biophys. J. 69 1995 2501–2506.
w x  .21 M.M. Bradford, Anal. Biochem. 72 1976 248–254.
w x22 S.B. Sato, T. Taguchi, S. Yamashita, S. Toyama, J. Biochem.
 .119 1996 887–897.
w x23 P.S. Uster, T.M. Allen, B.E. Daniel, C.J. Mendez, M.S.
 .Newman, G.Z. Zhu, FEBS Lett. 386 1996 243–246.
w x24 S. Felder, J. LaVin, A. Ullrich, J. Schlessinger, J. Cell Biol.
 .117 1992 203–212.
w x25 A. Sorkin, C. Waters, K.A. Overholer, G. Carpenter, J. Biol.
 .Chem. 266 1991 8355–8362.
w x26 A.M. Van der Bliek, T.E. Redelmeier, H. Damke, E.J.
Tisdale, E.M. Meyerowitz, S.L. Schmid, J. Cell Biol. 122
 .1993 553–563.
w x27 H. Damke, T. Baba, D.E. Warnock, S.L. Schmid, J. Cell
 .Biol. 127 1994 915–934.
w x  .28 C.R. Hopkins, I.S. Trowbridge, J. Cell Biol. 97 1983
508–521.
w x29 K. Miller, S. Shipman, I.S. Trowbridge, C. Hopkins, Cell 65
 .1991 621–632.
w x30 D.C. Litzinger, A.M.J. Buiting, N.v. Rooijen, L. Huang,
 .Biochim. Biophys. Acta 1190 1994 99–107.
w x31 N. Oku, Y. Tokudome, Y. Namba, N. Saito, M. Endo, Y.
Hasegawa, M. Kawai, H. Tsukada, S. Okada, Biochim.
 .Biophys. Acta 1280 1996 149–154.
w x  .32 K.C. Ingham, Methods Enzymol. 182 1990 301–306.
w x33 T.M. Allen, G.A. Austin, A. Chonn, L. Lin, K.C. LEE,
 .Biochim. Biophys. Acta 1061 1991 56–64.
w x  .34 H.M. Patel, Crit. Rev. Ther. Drug Carrier Syst. 9 1992
39–90.
w x  .35 E. Sackmann, in: R. Lipowsky, E. Sacksmann Eds. , Hand-
book of Biological Physics Vol. 1, Elsevier Science, Ams-
terdam, 1995, pp. 215–304.
w x  .36 N.E. Gabriel, M.F. Roberts, Biochemistry 23 1984 4011–
4015.
w x37 B.L.-S. Mui, H.-G. Dobereiner, T.D. Madden, P.R. Cullis,¨
 .Biophys. J. 69 1995 930–941.
w x38 K. Takei, P.S. Mcpherson, S.L. Schmid, P.D. Camilli, Na-
 .ture 374 1995 186–189.
w x  .39 J.E. Hinshaw, S.L. Schmid, Nature 374 1995 190–192.
w x  .40 J.R. Henley, M.A. McNiven, J. Cell Biol. 133 1996 761–
775.
